Effects of Deoxycytidine on Mycoplasma-Associated Inhibition of Thymidine Incorporation and Growth in Antifolate-Containing Media

Several mycoplasma species markedly inhibit lymphokine- and mitogen-induced 3H-thymidine incorporation in cultured lymphoid cells, but have negligible short-term effects on cellular DNA synthesis as assessed by cytofluorography or by cell counts. The deoxyribonucleotide precursor deoxycytidine (dC) reverses this inhibition, but has little effect on isotope incorporation in uninfected cultures. Human lymphoblastoid leukemia cell lines contaminated with mycoplasma and hypoxanthine guanosine phosphoribosyl transferase (HGPRT)-deficient subclones do not grow in conventional HAT medium, but the unselected parent lines proliferate when dC is included in the culture medium. The beneficial effect of dC on the growth of contaminated cultures in selection medium is amplified by the addition of the cytidine deaminase inhibitor tetrahydrouridine (THU). These observations and corroborating nucleotide pool analysis suggest that dC may exert its beneficial effects on cellular proliferation and isotope utilization by inhibiting a mycoplasma-associated enzyme, thymidine phosphorylase. The data also suggest that the conversion of dC to dU by the cellular enzyme cytidine deaminase reduces the ability of dC to salvage contaminated cultures in the presence of an antifolate. The addition of dC to the culture medium in various 3H-thymidine incorporation assays makes possible the detection of stimulatory lymphokines despite the presence of mycoplasma contamination of the indicator cells. The normalization of nucleotide pools and cellular growth of mycoplasma-infected HGPRT (+) human leukemic cell lines with the addition of dC to HAT selection medium has made possible the use of infected HGPRT-deficient subclones as fusion partners in the generation of T-T hybridomas. Our studies also suggest that the ability of cells to grow in HAT medium only when dC is included is presumptive evidence for mycoplasma infection.

[1]  F. Sinigaglia,et al.  Inhibition of [3H]thymidine incorporation by Mycoplasma arginini‐infected cells due to enzymatic cleavage of the nucleoside , 1985, European journal of immunology.

[2]  F. Sinigaglia,et al.  A sensitive and quantitative microassay for the detection of mycoplasma contamination: inhibition of IL-2 dependent cell line proliferation. , 1985, Journal of immunological methods.

[3]  G. Mcgarrity.  Mycoplasma infection of cell cultures: thymidine incorporation of culture supernatants as a screening test. , 1984, Journal of immunology.

[4]  S. K. Wadman,et al.  The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the interference with lymphocyte proliferation in vitro. , 1984, Journal of immunology.

[5]  E. Peterhans,et al.  Induction of chemiluminescence during interaction of tumoricidal effector cell populations and tumor cells is dependent on the presence of mycoplasma. , 1984, Journal of immunology.

[6]  E. Shevach,et al.  Mycoplasma contamination: a hazard of screening hybridoma supernatants for inhibition of [3H]thymidine incorporation. , 1984, Journal of immunological methods.

[7]  T. Braciale,et al.  Mycoplasma infection of cell cultures: thymidine incorporation of culture supernatants as a screening test. , 1984, Journal of immunology.

[8]  J. Yu,et al.  Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes. , 1983, Journal of immunology.

[9]  T. Triglia,et al.  A method for in vitro clearance of mycoplasma from human cell lines. , 1983, Journal of immunological methods.

[10]  N. Read,et al.  A comparison of preparative techniques for the examination of the external morphology of fungal material with the scanning electron microscope , 1983 .

[11]  M. Tattersall,et al.  The metabolic basis of deoxyuridine cytotoxicity. Studies of cultured human lymphoblasts. , 1982, Molecular pharmacology.

[12]  J. Mier,et al.  The purification and properties of human T cell growth factor. , 1982, Journal of immunology.

[13]  D. Hunting,et al.  Models of the regulation of ribonucleotide reductase and their evaluation in intact mammalian cells. , 1982, CRC critical reviews in biochemistry.

[14]  J. Charron,et al.  Analysis of deoxycytidine (dC) deaminase activity in herpes simplex virus-infected or HSV TK-transformed cells: association with mycoplasma contamination but not with virus infection. , 1981, The Journal of general virology.

[15]  R. Hopkins,et al.  Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. , 1981, Journal of immunology.

[16]  C. Dinarello,et al.  Ability of human leukocytic pyrogen to enhance phytohemagglutinin induced murine thymocyte proliferation. , 1981, Cellular immunology.

[17]  J. Peters,et al.  Mycoplasma contamination in human tumor cell lines: effect on interferon induction and susceptibility to natural killing. , 1981, Journal of immunology.

[18]  J. Mier,et al.  Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Mathews,et al.  Detection of activities that interfere with the enzymatic assay of deoxyribonucleoside 5'-triphosphates. , 1980, The Journal of biological chemistry.

[20]  J. Peters,et al.  Macrophages overcome mycoplasma infections of cells in vitro , 1980, Nature.

[21]  T. Pelliniemi,et al.  Biochemical mechanisms in the Killmann experiment: critique of the deoxyuridine suppression test. , 1980, The Journal of clinical investigation.

[22]  C. Chang,et al.  Substrate specificity of human ribonucleotide reductase from Molt-4F cells. , 1979, Cancer research.

[23]  R. Rees,et al.  High nonspecific reactivity of normal lymphocytes against rnycoplasma‐infected target cells in cytotoxicity assays , 1979, European journal of immunology.

[24]  P. Reichard,et al.  Reduction of ribonucleotides. , 1979, Annual review of biochemistry.

[25]  Kendall A. Smith,et al.  T cell growth factor: parameters of production and a quantitative microassay for activity. , 1978, Journal of immunology.

[26]  D. Phillips.  Detection of Mycoplasma Contamination of Cell Cultures by Electron Microscopy , 1978 .

[27]  T. Chen,et al.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. , 1977, Experimental cell research.

[28]  J. Fried,et al.  Flow cytofluorometric analysis of cell cycle distributions using propidium iodide. Properties of the method and mathematical analysis of the data , 1976, The Journal of cell biology.

[29]  W. D. Peterson,et al.  Identification of T cell lymphoma tumor antigens on human T cell lines , 1976, American journal of hematology.

[30]  W. Russell,et al.  A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses , 1975, Nature.

[31]  N. F. Friis,et al.  Some recommendations concerning primary isolation of Mycoplasma suipneumoniae and Mycoplasma flocculare a survey. , 1975, Nordisk veterinaermedicin.

[32]  G. I. Kagan.  [Mycoplasma infection of cell cultures]. , 1969, Vestnik Akademii meditsinskikh nauk SSSR.

[33]  B. Leventhal,et al.  Possible Mechanism for Mycoplasma Inhibition of Lymphocyte Transformation induced by Phytohaemagglutinin , 1968, Nature.

[34]  L. Hayflick,et al.  Altered nucleic acid metabolism in human cell cultures infected with mycoplasma. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Moore Ec,et al.  Regulation of Mammalian Deoxyribonucleotide Biosynthesis by Nucleotides as Activators and Inhibitors , 1966 .

[36]  E. Moore,et al.  Regulation of mammalian deoxyribonucleotide biosynthesis by nucleotides as activators and inhibitors. , 1966, The Journal of biological chemistry.

[37]  J. Horoszewicz,et al.  Change in pyrimidine deoxyribonucleoside metabolism in cell culture caused by Mycoplasma (PPLO) contamination. , 1963, Biochemical and biophysical research communications.